Oncology Venture presents positive data at ESMO on DRP as a response predictor for 5-FU treatment in colorectal cancer

by NASDAQ Market News September 22, 2019

NASDAQ Market News
Click here to email author

BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)

Innate Pharma files registration statement for proposed initial public offering in the United States

Ads